Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F6ZLR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,328
Award facts
- Contract value 100% obligated
- $22,327.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $22,327.81, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a firm fixed-price contract to supply Vraylar 1.5 mg capsules in quantities of 30 units. The contract was competitively awarded without set-aside designation and is scheduled for completion by January 30, 2026, just one day after the award date of January 29, 2026. Performance will occur at Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
The Defense Logistics Agency, operating under the Department of Defense, is funding this pharmaceutical procurement to support federal medical supply needs across military and veteran healthcare systems. Vraylar is a neurological medication used in the treatment of psychiatric conditions, representing one of numerous pharmaceutical products supplied by Amerisourcebergen through its expansive federal contract portfolio. The parent Indefinite Delivery Contract encompasses a broad range of pharmaceutical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, enabling efficient and flexible fulfillment of government healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26F6ZLR?
SPE2DR26F6ZLR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F6ZLR worth?
The government has obligated $22,328 on SPE2DR26F6ZLR.
Is contract SPE2DR26F6ZLR an order under another contract?
Yes. SPE2DR26F6ZLR is a delivery order under SPE2DR25D3803, an indefinite delivery contract.
Was contract SPE2DR26F6ZLR competed?
The extent of competition for SPE2DR26F6ZLR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award